Abdi Ibrahim Global Pharm

Abdi İbrahim founded Abdi İbrahim Global Pharm (AIGP) in 2012, after acquiring 60 percent stake in Global Pharm, one of the leading pharmaceutical producers of Kazakhstan. 

At the end of 2015, the country's most modern GMP production facility, which has been developed under AIGP, has commenced operations with an annual production capacity of 24 million boxes, marking the first overseas production of Abdi İbrahim. 

With a production facility extending over 12,000 square meters of indoor area, Abdi İbrahim Global Pharm is well on its way towards becoming a strong international brand, driven by its extensive portfolio of around 100 products, including mainly diabetes and antiviral products, as well as central nervous system and cardiovascular agents.

07_02
SITE MAP
INFORMATION SOCIETY SERVICES
© 2011-2017 Abdi İbrahim İlaç Sanayi ve Tic A.Ş.
The information provided on this site is not intended as an advice. Information provided should be discussed with your healthcare professional.
Phone: 0212 366 8400
E-Mail: info@abdiibrahim.com.tr